LYRA
Lyra Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.19
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -0.03x
- Price / sales
- 0.84x
- Price / cash flow
- -0.01x
Enterprise value
- Enterprise value
- $14.7M
- EV / sales
- 36.94x
- EV / EBITDA
- -0.47x
- EV / EBIT
- -0.47x
- Market cap
- $335.9K
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025